Menu

•    Faculty and Program Planners for ALL CPD events are required to complete a COI document on line in advance of the program.
•    These COI documents include questions related to any potential financial COI covering two years before the CPD program. CPD planning committee members, Chairs, Co-Chairs and Faculty are required to complete the disclosure document.
•    CAG has all these documents on file and they are required for each CPD application submitted to CAG for accreditation review.
•    COI documents are reviewed by CAG to identify in advance of any potential for bias and appropriate action is taken if required.
•    Participants are made aware of the Faculties disclosure information through standard disclosure slide (required for all CAG CPD events) at the beginning of the presentation and through a handout of disclosure information given to participants on site.
•    Information from faculty is requested if the presentation contains information related to the “off-label” use of drugs or devices. For therapeutics in evolution ‘off-label’ discussions are not uncommon in advance of approval for the indication. In pediatric GI almost all therapeutics are ‘off-label’ but form best practices in managing IBD even if specific pediatric indications may not be approved.
•    The Planning Committee of the CPD event reviews all disclosures and if any conflict is apparent this is discussed with the Chair of Education Affairs Committee and Chair of MOC if necessary.

In the situation of any significant COI; the conflict is resolved before the event or presentation through appropriate disclosure or other mechanism of resolution. Participants are advised of any potential COI through the written COI disclosure document included with meeting materials and by specific indication on the second slide of every Section One CAG CPD event.

Evaluation of COI by participants is part of the evaluation process. Any reports of perceived COI are discussed at the Education Affairs Committee and if appropriate Faculty are advised of any significant perception of COI in their presentations. To date this has not been required but the policy and process is in place.

If a perception of bias or conflict of interest is deemed significant by the Chair of Education Affairs;  then Faculty and program planners are advised and appropriate action is taken.

This is done as a continuous quality improvement initiative and not meant to be punitive but rather educational.  This then helps faculty and program planners in future program development and delivery of high quality CPD programs free of bias.
•    Participants receive a summary of all faculty and planning committee members’ disclosures with their meeting materials for CDDW™.
•    In addition the second slide of each presentation at CDDW™ and ALL CAG CPD programs is a disclosure slide specifically related to the faculty disclosure.
•    Faculty and all planning committee members are required to disclose to participants any specific potential COI interfaces in the preceding two years. This includes an indication from the presenter that if they are presenting their own research or paper they are required to indicate to the participants that this is their study.
•    No industry developed slides are allowed at CAG accredited events
•    At the introduction of meetings such as the CAG Education Affairs; committee members are asked to declare any potential COI related to the topics being discussed at the meeting.
•    All faculty and planning committee members are required to complete COI disclosure documents as described above.
•    These are summarized and included with the CPD program materials including CDs or videos.
•    Each presentation includes a standard template slide (slide 2) with declaration of any COI disclosure of planning committee and individual faculty members.
•    If presentations are at a distance (e-learning or webinars); faculty are required to include a COI declaration as the second slide in their presentation (such as on the CAG e-portal or on webinars.)
•    While impossible to “police” programs run as individual co-developed programs outside of the CDDW™; there have been intermittent audits of these presentations by members of the CAG Education Affairs Committee in a covert fashion to ensure adherence to the Standard.
•    The process of intermittent audit of  co-developed CPD programs has not revealed any issues related to inclusion of COI disclosure.
•    All faculty and chairs are required to complete a disclosure declaration in advance of the meeting and as part of the planning process for all CAG CPD activities. All Faculty; Chairs, Co-Chairs and planning committee members must complete a disclosure declaration.
•    As part of their disclosure declaration; speakers are asked to specify if their presentation/session includes discussion of any ‘off-label’ use of therapeutic interventions.
•    For therapeutics in evolution ‘off-label’ discussions are not uncommon in advance of approval for the indication. In pediatric GI almost all therapeutics are ‘off-label’ but form best practices in managing IBD even if specific pediatric indications may not yet be approved.
•    In addition Faculty are asked to use ‘generic’ names only in their slides
•    Faculty are asked to declare if any of their slides are provided by industry – if so then the slides must be vetted to ensure they are free from industry bias.
•    The Planning Committee of the CPD event reviews all disclosures and if any conflict is apparent this is discussed with the Chair of Education Affairs Committee and Chair of MOC if necessary.
Click here to download Disclosure Form Template and Disclosure Summary Template.

These Financial Disclosure forms are completed and valid for one year before they need to be updated.

Identification of potential conflict of interest will be reviewed by the planning committee and if corrective action is required in advance of the program, the faculty member will be advised and the conflict will be resolved. The learner will be presented with all conflict of interest declarations.